A commonly discussed concept in CitrusBurn reviews and consumer feedback is the idea of "clean energy.” This term is often ...

Singapore has one of the highest life expectancies in the world, yet many individuals spend almost a decade in poor health ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

Diabetic kidney disease is a leading cause of kidney failure worldwide, yet current treatments often slow progression ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

Omeros has won U.S. Food and Drug Administration approval of its Yartemlea treatment for an often-fatal complication of stem-cell transplants. Omeros on Wednesday said the approval covers Yartemlea ...

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...

Since its discovery, Alzheimer's disease has been considered irreversible. Consequently, research has focused on preventing or slowing the disease, rather than reversing it.  Using different mouse ...

AMD Phase 3 timing, Otsuka funding to 2028, and mixed 4D-710 data with financial risk. See why FDMT stock is a hold.

Also called C3G, this rare kidney disease often affects children and young adults, but it can happen at any age. It has a major impact on a person’s health and life. C3G has two forms: dense deposit ...

ABSTRACT: Food quality is one of the most important factors influencing animals’ immunity. In the present study, Siberian hamsters (Phodopus sungorus) were used to understand the effect of feeding ...